//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~subject:"Reimbursement"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject:"Fabry's-disease"
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Reimbursement
Fabry's-disease
2
Orphan-drugs
2
Bayesian-analysis
1
Chronic-myeloid-leukaemia
1
Cost-effectiveness
1
Cost-utility
1
Decision-making
1
Enzyme-stimulants
1
Formularies
1
Glucosylceramidase
1
Hereditary-angioedema
1
Pricing
1
Pulmonary-hypertension
1
Regulatory-process
1
Research-and-development
1
treatment
1
more ...
less ...
Online availability
All
Undetermined
1
Type of publication
All
Article
1
Language
All
Undetermined
1
Author
All
Blankart, Carl Rudolf.
1
Schreyogg, Jonas Schreygg
1
Stargardt, Tom
1
Published in...
All
PharmacoEconomics
1
Source
All
RePEc
1
Showing
1
-
1
of
1
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension,
Fabry
Disease
, Hereditary Angioedema and C...
Blankart, Carl Rudolf.
;
Stargardt, Tom
;
Schreyogg, …
- In:
PharmacoEconomics
29
(
2011
)
1
,
pp. 63-82
. Methods: Four rare diseases were selected for analysis: pulmonary arterial hypertension (PAH),
Fabry
disease
(FD), hereditary …
Persistent link: https://www.econbiz.de/10010614375
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->